Stay informed with the latest updates for the inheritable blood disorders community. Industry Investigational Sub-Q Von Willebrand Disease Therapy Put on Fast TrackJan 10, 2025 Industry Trial Updates for Investigational Hemophilia A Gene Therapy Shared at ASH…Dec 13, 2024 Industry Sanofi Announces Positive Data for Its Investigational ITP TherapyDec 11, 2024 Industry Star Therapeutics Presents Data on Investigational VWD Therapy Dec 10, 2024 Industry BioMarin to Narrow Its Commercial Focus for Hemophilia A Gene TherapyAug 13, 2024 Industry Pfizer Announces New Data from Hemophilia A Gene Therapy StudyAug 1, 2024 Industry FDA Approval Includes Full ALTUVIIIO™ Pediatric Trial Results May 17, 2024 Industry Hemophilia B Gene Therapy Trial Data Published Apr 8, 2024 Industry Takeda Announces Interim Trial Results for Investigational ITP TherapyMar 21, 2024 Industry Takeda's Voluntary Withdrawal: Alert on Misprinted Labels for VONVENDI®Jan 26, 2024 Industry FDA Accepts Biologics License Application for MarstacimabDec 14, 2023 Industry CSL Presents Three Year Treatment Data for Hemophilia B Gene TherapyDec 12, 2023 Industry FDA Grants Expanded Approval to Wilate® for Prophylaxis in All Types of…Dec 5, 2023 Industry First Patient Dosed with Hemophilia Gene Therapy Candidate ASC618Dec 4, 2023 Industry Sernova Receives Dual FDA Designations for Investigational Hemophilia…Nov 29, 2023 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page